Peter D Haytaian insider trades: Elevance Health (ELV) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Peter reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | ELV | ↓ Sell10b5-1 | 21,095 | $500.18 | $10.6M | Direct | Mar 5, 2024 (1d) |
| Mar 10, 2022 | ANTM | ↓ Sell | 17,703 | $460.71 | $8.2M | Direct | Mar 14, 2022 (4d) |
| Mar 22, 2021 | ANTM | ↓ Sell | 59,500 | $349.20 | $20.8M | Direct | Mar 23, 2021 (1d) |
| Dec 15, 2020 | ANTM | ↓ Sell | 5,833 | $312.53 | $1.8M | Direct | Dec 17, 2020 (2d) |
| Nov 16, 2020 | ANTM | ↓ Sell | 5,834 | $333.64 | $1.9M | Direct | Nov 18, 2020 (2d) |
| Oct 15, 2020 | ANTM | ↓ Sell | 5,834 | $291.95 | $1.7M | Direct | Oct 19, 2020 (4d) |
| Oct 9, 2020 | ANTM | ↓ Sell | 1,167 | $295.00 | $344K | Direct | Oct 13, 2020 (4d) |
| Oct 2, 2020 | ANTM | ↓ Sell | 4,667 | $280.00 | $1.3M | Direct | Oct 6, 2020 (4d) |
| Jun 8, 2020 | ANTM | ↓ Sell | 14,001 | $300.00 | $4.2M | Direct | Jun 10, 2020 (2d) |
| Dec 24, 2019 | ANTM | ↓ Sell | 8,333 | $303.57 | $2.5M | Direct | Dec 26, 2019 (2d) |
| Nov 18, 2019 | ANTM | ↓ Sell | 12,095 | $300.00 | $3.6M | Direct | Nov 20, 2019 (2d) |
| Oct 28, 2019 | ANTM | ↓ Sell | 9,586 | $269.57 | $2.6M | Direct | Oct 30, 2019 (2d) |
| Dec 27, 2018 | ANTM | ↓ Sell | 3,000 | $256.31 | $769K | Direct | Dec 28, 2018 (1d) |
| Nov 27, 2018 | ANTM | ↓ Sell | 4,500 | $278.48 | $1.3M | Direct | Nov 29, 2018 (2d) |
| Oct 31, 2018 | ANTM | ↓ Sell | 1,000 | $270.00 | $270K | Direct | May 7, 2021 (919d) |
| Oct 26, 2018 | ANTM | ↓ Sell | 3,500 | $267.59 | $937K | Direct | Oct 30, 2018 (4d) |
| Sep 27, 2018 | ANTM | ↓ Sell | 4,500 | $270.00 | $1.2M | Direct | Sep 28, 2018 (1d) |
| Sep 6, 2018 | ANTM | ↓ Sell | 2,936 | $270.00 | $793K | Direct | Sep 7, 2018 (1d) |
| Aug 27, 2018 | ANTM | ↓ Sell | 3,500 | $265.92 | $931K | Direct | Aug 29, 2018 (2d) |
| Dec 15, 2014 | ANTM | ↓ Sell | 649 | $123.73 | $80K | Direct | Dec 17, 2014 (2d) |
| Dec 8, 2014 | ANTM | ↓ Sell | 12,826 | $127.73 | $1.6M | Direct | Dec 10, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELV insiders
Open-market trades in the last 12 months
About Peter D Haytaian's insider trades
Peter D Haytaian is EVP & Pres Carelon & CarelonRx at Elevance Health (ELV). Since Dec 8, 2014, Peter has reported no open-market purchases and 21 sales worth $67.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (16% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (26 filings), grants and awards (14 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.